Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Донг-А Фарм. Ко., Лтд.filedCriticalДонг-А Фарм. Ко., Лтд.
Priority to UAA200813029ApriorityCriticalpatent/UA90805C2/en
Publication of UA90805C2publicationCriticalpatent/UA90805C2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
The present invention relates to three-branched polyethylene glycol-interferon alpha conjugate of general formula (1) wherein polyethylene glycol has an average molecular weight of from 400 to 45,000 daltons, and a pharmaceutical composition comprising the same.